Chromosome engineering and CRISPR-Cas9 viability screening reveals increased metastatic capacity targetable by patient-specific synthetic lethality

DSpace Repository

Chromosome engineering and CRISPR-Cas9 viability screening reveals increased metastatic capacity targetable by patient-specific synthetic lethality

Author: Nahnsen, Sven; Roessler, Stephanie; Schirmacher, Peter; Marquardt, Jens U.; Goeppert, Benjamin; Albrecht, Thomas; Pusch, Stefan; Jauch, Anna; Eiteneuer, Eva; Sticht, Carsten; Ibberson, David; Castven, Darko; Sugiyanto, Raisatun N.; Fritzsche, Sarah; Lemke, Steffen; Dreher, Emely; Huth, Thorben
Tübinger Autor(en):
Nahnsen, Sven
Lemke, Steffen
Published in: POSTER PRESENTATIONS: LIVER TUMOURS EXPERIMENTAL AND PATHOPHYSIOLOGY (2023-06), Bd.
Verlagsangabe: Elsevier
Language: English
Full text: https://doi.org/10.1016/S0168-8278(23)01323-5
DDC Classifikation: 004 - Data processing and computer science
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)